MARATTO

article · Sexual and Reproductive Health Matters

Access to assisted reproductive technologies in sub-Saharan Africa: fertility professionals’ views

202419 citationsOpen accessUniversity of the Witwatersrand

In plain language

Access to assisted reproductive technologies across sub-Saharan Africa faces significant challenges, with local healthcare experts offering diverse perspectives on how to address them. Qualitative interviews conducted between 2021 and 2023 with fertility specialists, embryologists, and clinic management across six countries highlighted multiple barriers. These obstacles include high treatment costs, an absence of public funding, limited policy prioritisation, few facilities, long travel distances for patients, and over-servicing in private clinics. All interviewed specialists agreed that government funding for public sector assisted reproduction is necessary to expand access. Proposed clinical strategies to lower costs included adopting mild stimulation protocols and performing oocyte retrieval under sedation rather than general anaesthetic. However, experts noted that a lack of clinical data on low-cost options and a severe shortage of skilled embryologists hinder implementation, while few proposed reducing clinic or pharmaceutical profit margins.

Key takeaways

  • Fertility specialists universally agreed that government funding in the public sector is essential to address access to assisted reproduction.
  • Major barriers include high medical costs, lack of public funding, long travel distances, and a shortage of specialised clinics and skilled embryologists.
  • Suggested approaches to lower costs involve mild stimulation protocols and conducting oocyte retrievals under sedation instead of general anaesthetics.
  • Implementation of low-cost interventions is impeded by insufficient performance data and a lack of skilled laboratory personnel.
  • Very few practitioners suggested reducing the profits of private clinics or pharmaceutical companies to lower treatment expenses.

Why it matters

Infertility affects many individuals across sub-Saharan Africa, yet assisted reproductive services remain largely out of reach. Understanding the operational, clinical, and financial barriers identified by regional practitioners is vital. This knowledge can help health authorities, policymakers, and service providers design more affordable, publicly supported treatments and expand specialised medical training programmes to meet pressing patient needs.

Commercialisation angle

The findings outline practical opportunities for developing lower-cost treatment protocols, such as simplified mild stimulation regimens and reduced-anaesthesia procedures, as well as targeted training programmes for embryologists. The primary users would be public and private fertility clinics and healthcare providers. Because experts cite a lack of data on low-cost interventions as a key barrier, these approaches remain at an early, exploratory stage requiring further clinical validation before wider rollout.

AI-generated from the published abstract. Always read the original work before citing.

Abstract

Across sub-Saharan Africa, there remains disagreement among local expert providers over the best ways to improve access to assisted reproduction in low-income contexts. Semi-structured qualitative interviews were conducted between 2021 and 2023 with 19 fertility specialists and 11 embryologists and one clinic manager from South Africa, Zimbabwe, Namibia, Kenya, Ethiopia and Uganda to explore issues surrounding access and potential low-cost IVF options. Lack of access to ART was variously conceptualised as a problem of high cost of treatment; lack of public funding for medical services and medication; poor policy awareness and prioritisation of fertility problems; a shortage of ART clinics and well-trained expert staff; the need for patients to travel long distances; and over-servicing within the largely privatised sector. All fertility specialists agreed that government funding for public sector assisted reproduction services was necessary to address access in the region. Other suggestions included: reduced medication costs by using mild stimulation protocols and oocyte retrievals under sedation instead of general anaesthetics. Insufficient data on low-cost interventions was cited as a barrier to their implementation. The lack of skilled embryologists on the continent was considered a major limitation to expanding ART services and the success of low-cost IVF systems. Very few specialists suggested that profits of pharmaceutical companies or ART clinics might be reduced to lessen the costs of treatments.

Research topics

  • Reproductive Health and Technologies
  • Assisted Reproductive Technology and Twin Pregnancy
  • Family Dynamics and Relationships

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/26410397.2024.2355790

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.